These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 18221786)

  • 1. Immunocapture-based fluorometric assay for the measurement of insulin-degrading enzyme activity in brain tissue homogenates.
    Miners JS; Kehoe PG; Love S
    J Neurosci Methods; 2008 Mar; 169(1):177-81. PubMed ID: 18221786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid.
    Miners JS; Verbeek MM; Rikkert MO; Kehoe PG; Love S
    J Neurosci Methods; 2008 Jan; 167(2):229-36. PubMed ID: 17904641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Somatostatin: a novel substrate and a modulator of insulin-degrading enzyme activity.
    Ciaccio C; Tundo GR; Grasso G; Spoto G; Marasco D; Ruvo M; Gioia M; Rizzarelli E; Coletta M
    J Mol Biol; 2009 Feb; 385(5):1556-67. PubMed ID: 19073193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation.
    Cordes CM; Bennett RG; Siford GL; Hamel FG
    Biochem Pharmacol; 2009 Mar; 77(6):1064-73. PubMed ID: 19154729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin acts intracellularly on proteasomes through insulin-degrading enzyme.
    Duckworth WC; Bennett RG; Hamel FG
    Biochem Biophys Res Commun; 1998 Mar; 244(2):390-4. PubMed ID: 9514933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined use of selective inhibitors and fluorogenic substrates to study the specificity of somatic wild-type angiotensin-converting enzyme.
    Jullien ND; Cuniasse P; Georgiadis D; Yiotakis A; Dive V
    FEBS J; 2006 Apr; 273(8):1772-81. PubMed ID: 16623712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A highly sensitive peptide substrate for detecting two Aß-degrading enzymes: neprilysin and insulin-degrading enzyme.
    Chen PT; Liao TY; Hu CJ; Wu ST; Wang SS; Chen RP
    J Neurosci Methods; 2010 Jun; 190(1):57-62. PubMed ID: 20435063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin degrading enzyme is localized predominantly at the cell surface of polarized and unpolarized human cerebrovascular endothelial cell cultures.
    Lynch JA; George AM; Eisenhauer PB; Conn K; Gao W; Carreras I; Wells JM; McKee A; Ullman MD; Fine RE
    J Neurosci Res; 2006 May; 83(7):1262-70. PubMed ID: 16511862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
    Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
    Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of Peptide Substrate for Sensitively and Specifically Detecting Two Aβ-Degrading Enzymes: Neprilysin and Angiotensin-Converting Enzyme.
    Chen PT; Chen CL; Lin LT; Lo CH; Hu CJ; Chen RP; Wang SS
    PLoS One; 2016; 11(4):e0153360. PubMed ID: 27096746
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-degrading enzyme.
    Authier F; Posner BI; Bergeron JJ
    Clin Invest Med; 1996 Jun; 19(3):149-60. PubMed ID: 8724818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired amyloid β-degrading enzymes in brain of streptozotocin-induced diabetic rats.
    Liu Y; Liu L; Lu S; Wang D; Liu X; Xie L; Wang G
    J Endocrinol Invest; 2011 Jan; 34(1):26-31. PubMed ID: 20414044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship between insulin-degrading enzyme activity and insulin sensitivity in cell model of insulin-resistance].
    Li CZ; Zhang SH; Shu CD; Ren W
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):151-4. PubMed ID: 12390813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin-degrading enzyme hydrolyzes ATP.
    Del Carmen Camberos M; Cresto JC
    Exp Biol Med (Maywood); 2007 Feb; 232(2):281-92. PubMed ID: 17259336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validated sandwich ELISA for the quantification of tissue transglutaminase in tissue homogenates and cell lysates of multiple species.
    Brevé JJ; Drukarch B; van Strien M; van Dam AM
    J Immunol Methods; 2008 Mar; 332(1-2):142-50. PubMed ID: 18279887
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate activation of insulin-degrading enzyme (insulysin). A potential target for drug development.
    Song ES; Juliano MA; Juliano L; Hersh LB
    J Biol Chem; 2003 Dec; 278(50):49789-94. PubMed ID: 14527953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The proteolytic activity of insulin-degrading enzyme: a mass spectrometry study.
    Grasso G; Rizzarelli E; Spoto G
    J Mass Spectrom; 2009 May; 44(5):735-41. PubMed ID: 19127548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PPARgamma transcriptionally regulates the expression of insulin-degrading enzyme in primary neurons.
    Du J; Zhang L; Liu S; Zhang C; Huang X; Li J; Zhao N; Wang Z
    Biochem Biophys Res Commun; 2009 Jun; 383(4):485-90. PubMed ID: 19383491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of insulin degrading enzyme by racecadotril in the brain of Wistar rats.
    Lee JP; Cheng KC; Chung HH; Wu HT; Chen CT; Cheng JT
    Horm Metab Res; 2011 Jun; 43(7):489-93. PubMed ID: 21557151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the binding of the fluorescent ATP analog TNP-ATP to insulysin.
    Yao H; Hersh LB
    Arch Biochem Biophys; 2006 Jul; 451(2):175-81. PubMed ID: 16723115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.